Problem statement: Answer the MCQ question.
Question: Which compound exhibits a 1.502\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a) Cc1cc(Nc2ccc(C)c(Br)c2)n2nc(C)nc2n1
b) CN(CC(=O)Nc1ccc(F)c(F)c1F)C(=O)c1ccc(-n2cncn2)c([N+](=O)[O-])c1
Answer: a. Cc1cc(Nc2ccc(C)c(Br)c2)n2nc(C)nc2n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cc(Nc2ccc(C)c(Br)c2)n2nc(C)nc2n1
Cc1cc(Nc2ccc(C)c(Br)c2)n2nc(C)nc2n1
N-(3-bromo-4-methylphenyl)-2,5-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine